Clinical Trial Update: Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating miltefosine for mucocutaneous leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmaniasis
• Mucocutaneous Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: Brasilia University Hospital | Conditions: Leishmaniasis, Leishmaniasis, Mucocutaneous | Phase 2 | Status: COMPLETED